Prot #CSTI571A2406: An open label, multi-center imatinib roll-over protocol for patients who have completed a previous Novartis-sponsored imatinib study and are judged by the investigator to benefit from continued imatinib treatment

Project: Research project

Project Details

StatusActive
Effective start/end date12/1/1212/31/21

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CSTI571A2406)